Skip to content
  • Sunday, 26 July 2026
  • 2:52 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s.
Laboratory Automation & Robotics

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s.

Lana Keisha Jun 22, 2026 0

A significant stride in the realm of integrated medicine has been reported by Remepy, a pioneering startup, as its innovative…

Read More
Laboratory Automation & Robotics

Novo Nordisk Transfers Parkinson’s Cell Therapy to Cellular Intelligence, Signaling New Era for AI-Driven Biopharma

Lana Keisha Jun 18, 2026 0

In a significant development for the burgeoning field of cell therapy and artificial intelligence in drug discovery, Cellular Intelligence, a…

Read More
Biotech & Genetic Research

Professor Peter Tessier Pioneers AI-Driven Solutions for Antibody Deliverability Challenges

Jia Lissa Jun 16, 2026 0

In a significant advancement for pharmaceutical sciences, Professor Peter Tessier, the esteemed Albert M. Mattocks Professor of Pharmaceutical Sciences and…

Read More
Laboratory Automation & Robotics

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s

Lana Keisha Jun 15, 2026 0

In a significant advancement for integrated medicine, Remepy, a pioneering startup, has announced successful Phase IIa clinical trial results for…

Read More
Laboratory Automation & Robotics

Pharmaceutical R&D Returns Soar to 7% Driven by GLP-1 Blockbusters, Raising Sustainability Questions for the Industry

Lana Keisha Jun 4, 2026 0

After a period characterized by uneven growth and strategic recalibrations in the wake of global health challenges, a key metric…

Read More
Pharmaceutical R&D

The Hereditary Angioedema Pharmaceutical Landscape Poised for Unprecedented Expansion Driven by Late-Stage Pipeline and Emerging Technologies

Teuku Ryan May 28, 2026 0

The pharmaceutical landscape for hereditary angioedema (HAE) is on the cusp of a significant transformation, marked by an unprecedented surge…

Read More
Molecular & Cell Biology

A New Study Reveals How Freezing and Thawing on Early Earth May Have Driven the Evolution of Life’s First Cells

Angie Faith May 25, 2026 0

The journey from inert organic molecules to the bustling, self-replicating entities we recognize as modern cells is one of science’s…

Read More
Laboratory Automation & Robotics

Insilico Medicine and Eli Lilly Forge Potentially $2.75 Billion AI-Driven Drug Discovery Alliance, Signaling a New Era of Pharmaceutical Innovation

Lana Keisha May 25, 2026 0

On March 29, Insilico Medicine, a pioneering company in artificial intelligence-driven drug discovery and development, announced a landmark collaboration with…

Read More
Clinical Diagnostics & Pathology

Walk-in Lab Testing in West Virginia Accelerates Consumer-Driven Healthcare, Reshaping Diagnostic Access and Clinical Laboratory Models

Reynand Amr Wu May 24, 2026 0

The landscape of healthcare diagnostics is undergoing a profound transformation, with West Virginia emerging as a key region illustrating this…

Read More
Biotech & Genetic Research

Billion Cell Atlas Unveiled: A New Horizon for AI-Driven Drug Discovery and Disease Understanding

Jia Lissa May 21, 2026 0

In a landmark initiative poised to revolutionize pharmaceutical research, scientists have announced the launch of the Billion Cell Atlas, an…

Read More

Posts pagination

1 2 3 … 5
TWiV 1293: The enemy of your parasite is your friendMitochondrial Energy Restoration Offers Potential Breakthrough in Addressing Cognitive Decline and Dementia ProgressionThe Ancient Story of Every Breath You Take: 289-Million-Year-Old Fossil Reveals Earliest Rib-Based Breathing System in AmniotesClosing the Information Gap: ETH Zürich Team Integrates Function and Binding in One Drug Screening Assay
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ